Fig. 6: Senescence-associated secretory phenotype.

A Box plots of circulating analytes significantly different in multimorbidity. B Plots of analytes correlating significantly with the number of comorbidities. C Analysis of the analyte panel in complex multimorbidity and in reduced datasets to test the influence of each comorbidity and anti-diabetic medications. The color indicates log fold change in multimorbidity. Numbers in square brackets indicate the number of non-multimorbid/multimorbid patients.